Synopsis
Synopsis
0
EU WC
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Alpha Heparin
2. Alpha-heparin
3. Heparin
4. Heparin Sodium
5. Heparin, Sodium
6. Heparin, Unfractionated
7. Heparinic Acid
8. Liquaemin
9. Unfractionated Heparin
1. (2s,3s,4r,5r,6r)-6-{[(2s,3s,4s,5r,6s)-6-{[(2r,3s,4s,5r)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)oxan-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)oxan-3-yl]oxy}-3-{[(2r,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylic Acid
2. Hepflush
3. Chembl526514
4. Gtpl4214
5. S01xa14
6. Bdbm50480251
7. (2s,3s,4r,5r,6r)-3-[(2r,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2s,3s,4s,5r,6s)-6-[(2r,3s,4s,5r)-2-carboxy-4,6-dihydroxy-5-sulfooxyoxan-3-yl]oxy-2-hydroxy-4-(sulfomethyl)-5-sulfooxyoxan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic Acid
1. 9005-49-6
Molecular Weight | 1039.9 g/mol |
---|---|
Molecular Formula | C26H41NO34S4 |
XLogP3 | -10.4 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 34 |
Rotatable Bond Count | 18 |
Exact Mass | 1039.0392821 g/mol |
Monoisotopic Mass | 1039.0392821 g/mol |
Topological Polar Surface Area | 589 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 2140 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 19 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Heparin sodium |
Drug Label | Intravenous solutions with heparin sodium (derived from porcine intestinal mucosa) are sterile, nonpyrogenic fluids for intravenous administration. They contain no bacteriostat or antimicrobial agent or added buffer. Edetate disodium, anhydrous is ad... |
Active Ingredient | Heparin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 5,000 units/ml; 10,000 units/ml; 20,000 units/ml; 1,000 units/ml |
Market Status | Prescription |
Company | Hospira; Shenzhen Techdow; Sandoz; Pfizer; Fresenius Kabi Usa; Hikma Maple; Sagent Pharms |
2 of 2 | |
---|---|
Drug Name | Heparin sodium |
Drug Label | Intravenous solutions with heparin sodium (derived from porcine intestinal mucosa) are sterile, nonpyrogenic fluids for intravenous administration. They contain no bacteriostat or antimicrobial agent or added buffer. Edetate disodium, anhydrous is ad... |
Active Ingredient | Heparin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 5,000 units/ml; 10,000 units/ml; 20,000 units/ml; 1,000 units/ml |
Market Status | Prescription |
Company | Hospira; Shenzhen Techdow; Sandoz; Pfizer; Fresenius Kabi Usa; Hikma Maple; Sagent Pharms |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-26
Pay. Date : 2014-04-03
DMF Number : 7944
Submission : 1989-03-02
Status : Active
Type : II
Registration Number : 218MF10052
Registrant's Address : 12150 Best Place Cincinnati, OH 45241-1569, U.S. S. A.
Initial Date of Registration : 2006-01-27
Latest Date of Registration :
NDC Package Code : 57262-378
Start Marketing Date : 2022-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 17838
Submission : 2004-11-03
Status : Active
Type : II
Registration Number : 302MF10020
Registrant's Address : C/Antic Cami de Tordera, 109-119, Palafolls, 08389 Barcelona, Spain
Initial Date of Registration : 2020-01-31
Latest Date of Registration :
NDC Package Code : 53484-001
Start Marketing Date : 2009-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9472
Submission : 1991-12-23
Status : Inactive
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5878
Submission : 1985-05-29
Status : Active
Type : II
NDC Package Code : 60870-0473
Start Marketing Date : 2021-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-09-15
Pay. Date : 2020-09-14
DMF Number : 2712
Submission : 1976-08-03
Status : Active
Type : II
Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.
NDC Package Code : 57262-300
Start Marketing Date : 1988-09-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-26
Pay. Date : 2014-04-03
DMF Number : 7944
Submission : 1989-03-02
Status : Active
Type : II
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31738
Submission : 2017-05-17
Status : Active
Type : II
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26680
Submission : 2013-01-07
Status : Active
Type : II
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : Complete
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 17838
Submission : 2004-11-03
Status : Active
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9472
Submission : 1991-12-23
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-16
Pay. Date : 2018-06-28
DMF Number : 9131
Submission : 1991-05-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5878
Submission : 1985-05-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-11
Pay. Date : 2022-08-16
DMF Number : 36291
Submission : 2021-09-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34686
Submission : 2020-03-17
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-15
Pay. Date : 2020-09-14
DMF Number : 2712
Submission : 1976-08-03
Status : Active
Type : II
Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.
About the Company : Smithfield BioScience specializes in harvesting and repurposing porcine-derived biological materials for use in pharmaceuticals, medical devices, regenerative medicine, and nutrace...
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
About the Company : Bioiberica is a global Life Science company with more than 45 years' experience in the production and development of molecules of high biological and therapeutic value for the phar...
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
...
About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with over 26 years of expertise in human and veterinary pharmaceuticals. Operating in 40+ countries, we own two st...
About the Company : HELM Portugal is HELM’s Competence Centre for the marketing of Active Pharmaceutical Ingredients (API). The leading APIs distributed by Helm include Ascorbic Acid pharma Grade (C...
About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...
About the Company : The company is a professional manufacturer of active biological extracts. We adhere to the market-oriented business philosophy. The international and domestic markets take advantag...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 9041-08-1
End Use API : Heparin Sodium
About The Company : Suanfarma founded in 1993, is a B2B life science partner committed to health advancement by developing, manufacturing, & distributing high-quality APIs for the ...
CAS Number : 9041-08-1
End Use API : Heparin Sodium
About The Company : Suanfarma founded in 1993, is a B2B life science partner committed to health advancement by developing, manufacturing, & distributing high-quality APIs for the ...
Regulatory Info :
Registration Country : Switzerland
Heparinum natricum; Symphyti radicis recentis extractum ethanolicum liquidum
Brand Name : Keppur
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Heparin
Dosage Form :
Dosage Strength : Coll 25,000 Iu 5 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Epsoclar 25000
Dosage Form : Heparin Sodium 25,000Iu 1 Unit Parenteral Use
Dosage Strength : 1 bottle EV 25,000 IU/5 ml 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Epsoclar
Dosage Form : Heparin Sodium 25,000Iu 10 Units Parenteral Use
Dosage Strength : 10 VIALS EV 25,000 IU 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Epsodilave
Dosage Form : Heparin Sodium 250Iu 10 Units Parenteral Use
Dosage Strength : 10 vials 250 IU 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Calciparina
Dosage Form : Calcium Heparin 12.500Iu 10 Units Parenteral Use
Dosage Strength : 10 SYRINGES SC 12,500 IU 0.5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Heparin LEO
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 5000 IU / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Heparin LEO
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 5000 IU / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Heparin LEO
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 5000 IU / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Reoflus
Dosage Form : Calcium Heparin 12.500Iu 10 Units Parenteral Use
Dosage Strength : 10 fialesiringhe SC 12,500 IU 0.5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 5000IU/ML
Packaging : 10 ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 10 ml
Regulatory Info :
Dosage : Vial
Dosage Strength : 5000IU/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 5000IU/ML
Packaging : 1 ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1 ml
Regulatory Info :
Dosage : Vial
Dosage Strength : 5000IU/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 20000IU/ML
Packaging : 1 ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1 ml
Regulatory Info :
Dosage : Vial
Dosage Strength : 20000IU/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5000IU/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Injection
Dosage Strength : 5000IU/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5000IU
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 5000IU
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Heparin
Dosage Form : Liquid Injection
Dosage Strength : 25000IU/ML
Packaging : 5 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 5 ML
Regulatory Info :
Dosage : Liquid Injection
Dosage Strength : 25000IU/ML
Brand Name : Heparin
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Brand Name : Heparinum
Dosage Form : Solution for IV Inject...
Dosage Strength : 25000IU/5ML
Packaging : 1 vial&10 vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 1 vial&10 vials
Regulatory Info :
Dosage : Solution for IV Inject...
Dosage Strength : 25000IU/5ML
Brand Name : Heparinum
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 2000IU/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Ampoule
Dosage Strength : 2000IU/2ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5000IU/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 5000IU/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5000IU/5ML
Packaging : 7.5 ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 7.5 ml
Regulatory Info :
Dosage : Injection
Dosage Strength : 5000IU/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Gel
Grade : Parenteral, Oral, Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral and Topical
Application : Parenteral
Dosage Form : Cream / Lotion / Ointment
Grade : Oral, Parenteral
Brand Name : Benzyl Alcohol Multi-Comp...
Application : Topical
Excipient Details : A&C’s Benzyl Alcohol multi-compendial is a preservative which meets USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Benzyl Alcohol Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : NaCl Multi-compendial Low...
Application : Parenteral
Excipient Details : A & C's Sodium Chloride multi-compendial low endotoxin is an excipient meeting USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Low Endotoxin
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Dosage Form : Tablet
Grade : Oral
Brand Name : Sodium Citrate Dihydrate ...
Application : Controlled & Modified Release
Excipient Details : A & C's Sodium Citrate Dihydrate multi-compendial is a trisodium salt of citric acid.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Sodium Citrate Dihydrate Excipient
Dosage Form : Tablet
Grade : Oral
Brand Name : Sodium Citrate Dihydrate ...
Application : Controlled & Modified Release
Excipient Details : A & C's Sodium Citrate Dihydrate USP-NF is a trisodium salt of citric acid.
Pharmacopoeia Ref : USP/NF
Technical Specs : Not Available
Ingredient(s) : Sodium Citrate Dihydrate Excipient
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
29
PharmaCompass offers a list of Heparin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Heparin Sodium manufacturer or Heparin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Heparin Sodium manufacturer or Heparin Sodium supplier.
PharmaCompass also assists you with knowing the Heparin Sodium API Price utilized in the formulation of products. Heparin Sodium API Price is not always fixed or binding as the Heparin Sodium Price is obtained through a variety of data sources. The Heparin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Heparin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Heparin, including repackagers and relabelers. The FDA regulates Sodium Heparin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Heparin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Heparin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Heparin supplier is an individual or a company that provides Sodium Heparin active pharmaceutical ingredient (API) or Sodium Heparin finished formulations upon request. The Sodium Heparin suppliers may include Sodium Heparin API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Heparin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Heparin DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Heparin active pharmaceutical ingredient (API) in detail. Different forms of Sodium Heparin DMFs exist exist since differing nations have different regulations, such as Sodium Heparin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Heparin DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Heparin USDMF includes data on Sodium Heparin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Heparin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Heparin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sodium Heparin Drug Master File in Japan (Sodium Heparin JDMF) empowers Sodium Heparin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sodium Heparin JDMF during the approval evaluation for pharmaceutical products. At the time of Sodium Heparin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sodium Heparin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sodium Heparin Drug Master File in Korea (Sodium Heparin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sodium Heparin. The MFDS reviews the Sodium Heparin KDMF as part of the drug registration process and uses the information provided in the Sodium Heparin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sodium Heparin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sodium Heparin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sodium Heparin suppliers with KDMF on PharmaCompass.
A Sodium Heparin CEP of the European Pharmacopoeia monograph is often referred to as a Sodium Heparin Certificate of Suitability (COS). The purpose of a Sodium Heparin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium Heparin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium Heparin to their clients by showing that a Sodium Heparin CEP has been issued for it. The manufacturer submits a Sodium Heparin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium Heparin CEP holder for the record. Additionally, the data presented in the Sodium Heparin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium Heparin DMF.
A Sodium Heparin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium Heparin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium Heparin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Heparin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Heparin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Heparin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Heparin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Heparin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Heparin suppliers with NDC on PharmaCompass.
Sodium Heparin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Heparin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Heparin GMP manufacturer or Sodium Heparin GMP API supplier for your needs.
A Sodium Heparin CoA (Certificate of Analysis) is a formal document that attests to Sodium Heparin's compliance with Sodium Heparin specifications and serves as a tool for batch-level quality control.
Sodium Heparin CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Heparin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Heparin may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Heparin EP), Sodium Heparin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Heparin USP).